MLICM
ALB icon

Metropolitan Life Insurance Company (MetLife)’s Albemarle ALB Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ALB Stock Details ALB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,733
Closed -$624K – 86
2024
Q1 		$624K Sell
4,733
-43
-0.9% -$5.29K 0.03% 437
2023
Q4 		$690K Sell
4,776
-79
-2% -$10.8K 0.03% 403
2023
Q3 		$826K Sell
4,855
-259
-5% -$51.6K 0.04% 335
2023
Q2 		$1.14M Sell
5,114
-126
-2% -$25.8K 0.06% 301
2023
Q1 		$1.16M Sell
5,240
-1,261
-19% -$311K 0.06% 295
2022
Q4 		$1.41M Sell
6,501
-303
-4% -$80.8K 0.06% 289
2022
Q3 		$1.8M Sell
6,804
-82
-1% -$20.9K 0.09% 229
2022
Q2 		$1.44M Sell
6,886
-167
-2% -$37.3K 0.06% 287
2022
Q1 		$1.56M Sell
7,053
-6,136
-47% -$1.3M 0.06% 313
2021
Q4 		$3.08M Sell
13,189
-296
-2% -$73.2K 0.04% 352
2021
Q3 		$2.95M Sell
13,485
-443
-3% -$94.6K 0.04% 353
2021
Q2 		$2.35M Sell
13,928
-169
-1% -$27.3K 0.03% 453
2021
Q1 		$2.06M Buy
14,097
+590
+4% +$94.7K 0.03% 502
2020
Q4 		$1.99M Sell
13,507
-992
-7% -$118K 0.03% 475
2020
Q3 		$1.29M Sell
14,499
-636
-4% -$56.3K 0.02% 605
2020
Q2 		$1.17M Sell
15,135
-883
-6% -$60K 0.02% 646
2020
Q1 		$903K Sell
16,018
-61
-0.4% -$4.67K 0.02% 731
2019
Q4 		$1.17M Buy
16,079
+44
+0.3% +$2.94K 0.02% 799
2019
Q3 		$1.11M Buy
16,035
+44
+0.3% +$3K 0.02% 802
2019
Q2 		$1.13M Buy
15,991
+1,031
+7% +$76.1K 0.02% 830
2019
Q1 		$1.23M Sell
14,960
-455
-3% -$37.2K 0.02% 766
2018
Q4 		$1.19M Sell
15,415
-204
-1% -$19.3K 0.02% 704
2018
Q3 		$1.56M Sell
15,619
-938
-6% -$90.8K 0.03% 664
2018
Q2 		$1.56M Sell
16,557
-1,433
-8% -$138K 0.03% 666
2018
Q1 		$1.67M Buy
17,990
+118
+0.7% +$13K 0.02% 646
2017
Q4 		$2.29M Sell
17,872
-35,170
-66% -$4.77M 0.03% 471
2017
Q3 		$7.23M Sell
53,042
-952
-2% -$113K 0.05% 359
2017
Q2 		$5.7M Sell
53,994
-1,425
-3% -$155K 0.04% 492
2017
Q1 		$5.85M Sell
55,419
-782
-1% -$76.1K 0.04% 486
2016
Q4 		$4.84M Sell
56,201
-1,982
-3% -$168K 0.03% 590
2016
Q3 		$4.97M Sell
58,183
-47,297
-45% -$3.89M 0.04% 537
2016
Q2 		$8.37M Buy
105,480
+3,747
+4% +$275K 0.06% 292
2016
Q1 		$6.5M Buy
101,733
+2,918
+3% +$160K 0.05% 385
2015
Q4 		$5.54M Buy
98,815
+408
+0.4% +$21K 0.04% 450
2015
Q3 		$4.34M Sell
98,407
-848
-0.9% -$41.4K 0.03% 571
2015
Q2 		$5.49M Sell
99,255
-1,081
-1% -$64.5K 0.04% 492
2015
Q1 		$5.3M Buy
100,336
+32,401
+48% +$1.77M 0.04% 500
2014
Q4 		$4.08M Buy
67,935
+645
+1% +$38K 0.03% 638
2014
Q3 		$3.96M Sell
67,290
-592
-0.9% -$38.5K 0.03% 630
2014
Q2 		$4.85M Buy
67,882
+205
+0.3% +$14.1K 0.03% 560
2014
Q1 		$4.5M Sell
67,677
-242
-0.4% -$15.7K 0.03% 581
2013
Q4 		$4.3M Buy
67,919
+291
+0.4% +$19.3K 0.03% 586
2013
Q3 		$4.26M Sell
67,628
-4,473
-6% -$282K 0.03% 554
2013
Q2 		$4.49M Buy
+72,101
New +$4.53M 0.04% 491

Other funds holding ALB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Metropolitan Life Insurance Company (MetLife)'s ALB Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Albemarle (ALB) in Q2 2024, closing a stake of 4,733 shares — an estimated $624K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ALB in Q2 2013 and held it in 44 quarters. The position peaked at $8.37M in Q2 2016. 844 funds tracked by Wall St. Rank hold ALB as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Albemarle position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 4,733 Albemarle shares in Q2 2024, an estimated $624K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Albemarle in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Albemarle position peaked at $8.37M in Q2 2016.
  • 844 funds tracked by Wall St. Rank held Albemarle as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.